Original ArticlesDonor-Specific HLA Antibodies in a Cohort Comparing Everolimus With Cyclosporine After Kidney Transplantation
Under a Creative Commons license
open archive
Key words:
Antibody-mediated rejection
cyclosporine
donor-specific antibodies
everolimus
kidney transplantation
immunosuppression
Abbreviations:
AMR
antibody-mediated rejection
AR
acute rejection
CD
deceased donor
CI
confidence interval
CNI
calcineurin-inhibitor
CyA
cyclosporine A
DSA
donor-specific HLA antibodies
EC-MPS
enteric-coated mycophenolate sodium
EVR
everolimus
FSGS
focal segmental glomerulosclerosis
GFR
glomerular filtration rate
GN
glomerulonephritis
HLA
human leucocyte antigen(s)
HR
hazard ratio
IS
immunosuppression
ITT
intention to treat
KTX
kidney transplantation
LD
living donor
MDRD
modification in diet in renal disease
MPS
mycophenolate sodium
MP
methylprednisolone
mTORi
mammalian target of rapamycin inhibitor
PRA
panel reactive antibodies
SD
standard deviation
Tac
tacrolimus
TCMR
T-cell-mediated rejection
Cited by (0)
- †
S.B. and L.L. contributed equally to the study.
Copyright © 2012 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.